Company Information

    Gemini Therapeutics was founded on January 2015. The company is based in Cambridge, MA, USA . The number of employees in Gemini Therapeutics is less than 50. Gemini therapeutics focuses on genetically-defined dry age-related macular degeneration (amd) and associated rare genetic diseases.

    Here is how Gemini Therapeutics describes itself: "Gemini Therapeutics is a precision medicine company focused on the development of new therapies through a deeper understanding of disease."
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Gemini Therapeutics has received 2 rounds of venture funding. The total funding amount is around $44.5M.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        Gemini Therapeutics - Blog


                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *